C12N 2710/16011
Herpesviridae
C12N2710/16011 (Herpesviridae) appears on 2,428 US grants and 2,844 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,428
- Published applications
- 2,844
- Assignees
- 1,293
- Inventors
- 5,091
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 8 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 8 | 0 |
| 1987 | 16 | 0 |
| 1988 | 14 | 0 |
| 1989 | 14 | 0 |
| 1990 | 10 | 0 |
| 1991 | 19 | 0 |
| 1992 | 28 | 0 |
| 1993 | 33 | 0 |
| 1994 | 30 | 0 |
| 1995 | 29 | 0 |
| 1996 | 38 | 0 |
| 1997 | 73 | 0 |
| 1998 | 142 | 0 |
| 1999 | 89 | 0 |
| 2000 | 106 | 0 |
| 2001 | 102 | 25 |
| 2002 | 70 | 90 |
| 2003 | 74 | 106 |
| 2004 | 58 | 109 |
| 2005 | 39 | 85 |
| 2006 | 48 | 74 |
| 2007 | 35 | 70 |
| 2008 | 40 | 75 |
| 2009 | 42 | 75 |
| 2010 | 51 | 82 |
| 2011 | 43 | 88 |
| 2012 | 38 | 79 |
| 2013 | 42 | 89 |
| 2014 | 60 | 96 |
| 2015 | 57 | 106 |
| 2016 | 59 | 108 |
| 2017 | 86 | 118 |
| 2018 | 77 | 130 |
| 2019 | 117 | 141 |
| 2020 | 100 | 166 |
| 2021 | 79 | 165 |
| 2022 | 97 | 196 |
| 2023 | 81 | 170 |
| 2024 | 87 | 149 |
| 2025 | 99 | 156 |
| 2026 | 57 | 96 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/16611SimplexvirusIndexing code999
- C12N 2710/16111CytomegalovirusIndexing code538
- C12N 2710/16711VaricellovirusIndexing code486
- C12N 2710/16211LymphocryptovirusIndexing code345
- C12N 2710/16311MardivirusIndexing code177
- C12N 2710/16034Use of virus or viral component as vaccineIndexing code118
- C12N 2710/16411RhadinovirusIndexing code74
- C12N 2710/16041Use of virus, viral particle or viral elements as a vectorIndexing code62
All 19 subgroupsShow fewer
- C12N 2710/16022New viral proteins or individual genes, new structural or functional aspects ofIndexing code61
- C12N 2710/16511RoseolovirusIndexing code36
- C12N 2710/16021Viruses as suchIndexing code33
- C12N 2710/16061Methods of inactivation or attenuationIndexing code30
- C12N 2710/16071Demonstrated in vivo effectIndexing code18
- C12N 2710/16051Methods of production or purification of viral materialIndexing code13
- C12N 2710/16033Use of viral protein as therapeutic agent other than vaccineIndexing code9
- C12N 2710/16023Virus like particles [vlp]Indexing code4
- C12N 2710/16032Use of virus as therapeutic agent, other than vaccineIndexing code3
- C12N 2710/16031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2710/16088For redistributionIndexing code0
Recent patents
- Method for production of Varicella Zoster Virus surface protein antigen29 Sep 2026US 12,747,427 B2The Green Cross Corporation
- Sequential heterologous boost oncolytic viral immunotherapy25 Aug 2026US 12,714,733 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancer18 Aug 2026US 12,708,653 B2Endeavor Health Clinical Operations
- Stable frozen virus formulation11 Aug 2026US 12,702,688 B2Amgen Inc.
- Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof11 Aug 2026US 12,702,707 B2The Trustees of the University of Pennsylvania
- Recombinant herpes simplex virus with il-12 expression8 Oct 2026US 2026/0308219 A1
- Metabolic switches for anti-tumor immunity8 Oct 2026US 2026/0308516 A1Cold Spring Harbor Laboratory
- Compositions of mrna-encoded virus-like particles, compositions of mrna-lipid nanoparticles, and methods for use thereof1 Oct 2026US 2026/0295033 A1
- Mutated fragment of vzv glycoprotein e1 Oct 2026US 2026/0295035 A1
- Rna for preventing or treating tuberculosis24 Sep 2026US 2026/0284168 A1
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Production of recombinant adeno-associated virus vectors369US 5,173,414 AApplied Immune Sciences, Inc. · 1992
- Modified vaccinia virus298US 4,603,112 AHealth Research, Inc. · 1986
- Modified vaccinia virus and methods for making and using the same264US 4,769,330 AHealth Research, Inc. · 1988
- Method for immunizing animals with synthetically modified vaccinia virus240US 4,722,848 AHealth Research, Inc. · 1988